Valartin Pharma

Valartin Pharma is a modern Ukrainian pharmaceutical company that develops, manufactures and promotes competitive medicines and health products (dietary supplements).

The name of the company takes its roots from the Latin Valeo artis - the art of creating health. This is precisely the mission of our company - to provide patients with access to pharmaceutical care, which is one of the main components of healthcare accessibility.

Despite the young age of the company, it has brought together some of the best professionals in the pharmaceutical industry in Ukraine.

The heads of the company and its key competencies have been actively working in the domestic pharmaceutical market for more than 20 years.

The main goal of Valartin Pharma LLC is to meet the needs of consumers for safe, effective, high-quality and economically affordable drugs by introducing modern technologies and a quality assurance system at all stages of the product life cycle.

The company is an expert in the production of medical sorbents based on activated carbon, including in combination with plant extracts. The company's product line under the Sorbex brand is widely known and in demand by consumers in Ukraine, Russia, the CIS countries, the Baltic States, Poland, Bulgaria, and Finland.

Valartin Pharma LLC with its products is actively represented by medicinal preparations based on plant extracts used in cardiology and gynecology. A separate serious product line of the enterprise is drugs for the treatment of viral hepatitis B and C (combined hepatoprotectors, medical immuno-biological drugs interferon alpha-2B, antiviral drugs).

The company was able to attract investment, thanks to which it acquired the rights to develop, register and market innovative products for the treatment of viral hepatitis.

Among them is the first domestic pegylated interferon alpha-2b, which was developed by leading Ukrainian scientists and in October 2012 received permission from the Ministry of Health for medical use in Ukraine